These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 21811247)

  • 21. Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys.
    Hordeaux J; Hinderer C; Buza EL; Louboutin JP; Jahan T; Bell P; Chichester JA; Tarantal AF; Wilson JM
    Hum Gene Ther; 2019 Aug; 30(8):957-966. PubMed ID: 31017018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
    Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
    Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
    Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
    Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal Delivery of AAV Vectors in Cynomolgus Macaques for CNS Gene Therapy and Gene Expression Analysis in Microdissected Motor Neurons.
    Borel F; Adams E; Mueller C
    Methods Mol Biol; 2019; 1937():295-303. PubMed ID: 30706405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy.
    Little D; Valori CF; Mutsaers CA; Bennett EJ; Wyles M; Sharrack B; Shaw PJ; Gillingwater TH; Azzouz M; Ning K
    Mol Ther; 2015 Feb; 23(2):270-7. PubMed ID: 25369768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons.
    Foust KD; Poirier A; Pacak CA; Mandel RJ; Flotte TR
    Hum Gene Ther; 2008 Jan; 19(1):61-70. PubMed ID: 18052722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates.
    Ellsworth JL; Gingras J; Smith LJ; Rubin H; Seabrook TA; Patel K; Zapata N; Olivieri K; O'Callaghan M; Chlipala E; Morales P; Seymour A
    PLoS One; 2019; 14(11):e0225582. PubMed ID: 31770409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes.
    Chandran J; Chowdhury EA; Perkinton M; Jamier T; Sutton D; Wu S; Dobson C; Shah DK; Chessell I; Meno-Tetang GML
    Gene Ther; 2023 Feb; 30(1-2):132-141. PubMed ID: 35637286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
    Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
    Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy.
    Pattali R; Mou Y; Li XJ
    Gene Ther; 2019 Aug; 26(7-8):287-295. PubMed ID: 31243392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle.
    Zhu H; Wang T; John Lye R; French BA; Annex BH
    J Gene Med; 2018 Sep; 20(9):e3049. PubMed ID: 30101537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques.
    Gombash SE; Cowley CJ; Fitzgerald JA; Lepak CA; Neides MG; Hook K; Todd LJ; Wang GD; Mueller C; Kaspar BK; Bielefeld EC; Fischer AJ; Wood JD; Foust KD
    Gene Ther; 2017 Oct; 24(10):640-648. PubMed ID: 28771235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors.
    Miyake N; Miyake K; Yamamoto M; Hirai Y; Shimada T
    Brain Res; 2011 May; 1389():19-26. PubMed ID: 21397590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
    Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
    Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
    McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
    Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.
    Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA
    Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice.
    Iida A; Takino N; Miyauchi H; Shimazaki K; Muramatsu S
    Biomed Res Int; 2013; 2013():974819. PubMed ID: 23762870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery.
    Dufour BD; McBride JL
    Methods Mol Biol; 2016; 1364():261-75. PubMed ID: 26472457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.